{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:12:48Z","timestamp":1792761168036,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770598"],"award-info":[{"award-number":["81770598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000533"],"award-info":[{"award-number":["82000533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019398","name":"Beijing Friendship Hospital, Capital Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.hbpd.2022.05.009","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T12:10:41Z","timestamp":1653394241000},"page":"577-582","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis"],"prefix":"10.1016","volume":"21","author":[{"given":"Sha","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jia","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu-Er","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Dong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2022.05.009_bib0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"European association for the study of the liver. EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0002","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/391567","article-title":"Rheumatoid arthritis and primary biliary cirrhosis: cause, consequence, or coincidence?","volume":"2012","author":"Smyk","year":"2012","journal-title":"Arthritis"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0003","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","article-title":"Primary biliary cirrhosis and Sj\u00f6gren's syndrome: autoimmune epithelitis","volume":"39","author":"Selmi","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0004","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5009\/gnl16365","article-title":"Extrahepatic manifestations of primary biliary cholangitis","volume":"11","author":"Chalifoux","year":"2017","journal-title":"Gut Liver"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0005","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/jgh.15214","article-title":"Extrahepatic autoimmune diseases in primary biliary cholangitis: prevalence and significance for clinical presentation and disease outcome","volume":"36","author":"Efe","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5557814","article-title":"Clinical characteristics and prognosis of concomitant primary biliary cholangitis and autoimmune diseases: a retrospective study","volume":"2021","author":"Liu","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0007","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7396870","article-title":"Concomitant Sj\u00f6gren's syndrome was not associated with a poorer response or outcomes in ursodeoxycholic acid-treated patients with primary biliary cholangitis","volume":"2019","author":"Ni","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0008","doi-asserted-by":"crossref","first-page":"e2537","DOI":"10.1097\/MD.0000000000002537","article-title":"Increased risks of spontaneous bacterial peritonitis and interstitial lung disease in primary biliary cirrhosis patients with concomitant Sj\u00f6gren syndrome","volume":"95","author":"Chen","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0009","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0010","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary biliary cholangitis: 2018 practice guidance from the American association for the study of liver diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0011","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0012","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0013","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2014.01.007","article-title":"Hashimoto thyroiditis: clinical and diagnostic criteria","volume":"13","author":"Caturegli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0014","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cre2.489","article-title":"The effects of cigarette smoking on the salivary and tongue microbiome","volume":"8","author":"Suzuki","year":"2022","journal-title":"Clin Exp Dent Res"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0015","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.20907","article-title":"Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients","volume":"42","author":"Gershwin","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0016","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/1751-2980.12687","volume":"20","author":"Li","year":"2019","journal-title":"J Dig Dis"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/kjhep.2012.18.1.1","article-title":"Revision and update on clinical practice guideline for liver cirrhosis","volume":"18","author":"Suk","year":"2012","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0018","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0019","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","article-title":"Optimising risk stratification in primary biliary cirrhosis: AST\/platelet ratio index predicts outcome independent of ursodeoxycholic acid response","volume":"60","author":"Trivedi","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0020","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1053\/j.gastro.2015.07.061","article-title":"Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy","volume":"149","author":"Lammers","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0021","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","article-title":"Extrahepatic autoimmune conditions associated with primary biliary cirrhosis","volume":"48","author":"Floreani","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2188\/jea.15.24","article-title":"A cross-sectional study of primary biliary cirrhosis in Japan: utilization of clinical data when patients applied to receive public financial aid","volume":"15","author":"Sakauchi","year":"2005","journal-title":"J Epidemiol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0023","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0676.1995.tb00110.x","article-title":"Prediction of prognosis of primary biliary cirrhosis in Japan","volume":"15","author":"Inoue","year":"1995","journal-title":"Liver"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0024","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/ard.60.11.1046","article-title":"Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients","volume":"60","author":"Marasini","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ajg.2016.479","article-title":"Thyroid dysfunction in primary biliary cholangitis: a comparative study at two European centers","volume":"112","author":"Floreani","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0026","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2022.05.009_bib0027","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.rhu.0000099623.30805.2f","article-title":"Association of primary biliary cirrhosis and rheumatoid arthritis","volume":"9","author":"Siegel","year":"2003","journal-title":"J Clin Rheumatol"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387222001278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387222001278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:43:53Z","timestamp":1761493433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387222001278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1499387222001278"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2022.05.009","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2022.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}